Leef Brands (LEEEF) Receivables (2023 - 2026)

Leef Brands (LEEEF) reported Receivables of $2.6 million for Q1 2026, up 65.39% sequentially from $1.6 million in Q4 2025.

Leef Brands (LEEEF) Receivables (2023 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 4 years of Receivables data on file, last reported at $2.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Receivables changed N/A year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (changed N/A YoY), and the FY2025 full-year result was $1.6 million, down 33.49% from the prior year.
  • Receivables advanced to $2.6 million in Q1 2026, from $1.6 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $2.6 million in Q1 2026 to a low of $1.6 million in Q4 2025.
  • A 4-year average of $2.3 million and a median of $2.5 million in 2023 frame the typical range for Receivables.
  • Across the five-year window, Receivables fell 5.36% in 2024 and sank 33.49% in 2025, its largest moves.
  • Tracing LEEEF's Receivables over 4 years: stood at $2.5 million in 2023, then slipped by 5.36% to $2.4 million in 2024, then slumped by 33.49% to $1.6 million in 2025, then jumped by 65.39% to $2.6 million in 2026.
  • Business Quant data shows LEEEF's Receivables at $2.6 million in Q1 2026, $1.6 million in Q4 2025, and $2.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 2.99 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.39 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.51 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 6.46 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 312.00 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.29 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 3.58 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 768.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.15 Bn
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn 2.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.63 Mn
Dec 31, 2025 1.59 Mn
Dec 31, 2024 2.39 Mn
Dec 31, 2023 2.53 Mn